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Abstract
Background Few studies have evaluated patients’ per-
ceived burden of cancer surveillance tests. Cancer screen-
ing and surveillance, however, require a large number of
patients to undergo potentially burdensome tests with only
some experiencing health gains from it. We investigated
the determinants of patients’ reported burden of upper
gastrointestinal (GI) endoscopy by comparing data from
three patient groups.
Patients and methods A total of 476 patients were
included: 180 patients under regular surveillance for
Barrett esophagus (BE), a premalignant disorder; 214
patients with non-speciﬁc upper GI symptoms (NS), and 82
patients recently diagnosed with upper GI cancer (CA). We
assessed pain, discomfort and overall burden experienced
during endoscopy, symptoms in the week afterwards and
psychological distress over time (Hospital Anxiety and
Depression scale and Impact of Event Scale).
Results Two-thirds (66%) of patients reported discomfort
and overall burden of upper GI endoscopy. Only 23%
reported any pain. BE patients reported signiﬁcantly less
discomfort, pain and overall burden than the other patients:
those with NS reported more discomfort, CA patients more
pain, and both more overall burden. These differences
could be statistically explained by the number of previous
endoscopies and whether sedation was provided or not, but
not by patient characteristics.
Conclusion The perception of upper GI endoscopy varies
by patient group, due to potential adaptation after multiple
endoscopies and aspects of the procedure.
Keywords Upper gastrointestinal endoscopy 
Endoscopic surveillance  Barrett esophagus  Perceived
patient burden  Discomfort  Anxiety  Distress
Introduction
Opportunities for screening and surveillance of premalig-
nant conditions have increased and will increase in the
future. However, such interventions can be burdensome,
and, as in any screening situation, the number of subjects
exposed to this burden is often much higher than the
number of subjects experiencing the beneﬁcial health
effects of the screening [1].
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DOI 10.1007/s11136-007-9239-8Upper gastrointestinal (GI) endoscopy is commonly
used to diagnose and treat patients with a range of condi-
tions and symptoms. Complications related to upper GI
endoscopy are rare, and it is considered to be a safe pro-
cedure [2, 3]. Patients with Barrett esophagus (BE), a
premalignant condition mostly without physical symptoms
but associated with an increased risk of developing
esophageal adenocarcinoma of 0.5% per year, are recom-
mended to undergo regular biennial endoscopic surveil-
lance for early detection of esophageal cancer [4]. All
patients participating in surveillance experience the pain
and discomfort of biennial upper GI endoscopy, whereas
progression to adenocarcinoma occurs only in a minority of
BE patients [5–8] and undisputable evidence that surveil-
lance prolongs survival is still lacking [9–12]. Hence, the
patients’ perceived burden of upper GI endoscopy testing
needs to be taken in to account in evaluating the health
beneﬁts of surveillance of subjects with BE.
In some situations, there is a trade-off between the
effectiveness of screening (or surveillance) and the test
uptake. For example, colorectal cancer screening using
sigmoidoscopy is more effective than faecal occult blood
testing [13]. At present, this trade-off is not relevant for
surveillance of BE because a less burdensome test than
upper GI endoscopy is not available, but the recognition
that upper GI endoscopy is burdensome may prompt a
reconsideration of the frequency of surveillance. Ongoing
studies aim to identify groups of BE patients at lower risk
of developing esophageal cancer than others, so that
offering less frequent surveillance may be warranted [14].
At the patient level, empirical data on perceived burden
of upper GI endoscopy can be used in the process of
informing subjects with BE who consider participation to a
surveillance programme. In a general sense, empirical data
of the patients’ perceived burden of testing may contribute
to subjects’ informed decision-making on participation (or
non-participation) to screening or surveillance and hence,
to quality of health care [15].
Studying the determinants of patients’ perceived burden
of upper GI endoscopy, e.g. by comparing data from dif-
ferent patient groups, may allow for the identiﬁcation of
patient groups who are likely to experience more pain or
discomfort than others. This information can be used in
practice guidelines, e.g. on provision of sedation to prevent
pain and discomfort, or other types of patient support.
Studying determinants of patients’ perceived burden is of
additional interest from the perspective of evaluation re-
search. If patients’ perception of the burden of endoscopy
differs by the context of e.g., surveillance or diagnostic
work-up, the generalisability of data from one context to
another is limited.
Our previous work [16] has shown that BE patients
under regular surveillance perceive upper GI endoscopy as
burdensome. They experienced anxiety and discomfort, but
hardly reported pain or symptoms. We analysed potential
determinants of the perceived burden of upper GI endos-
copy by comparing BE patients with two additional patient
groups, i.e., patients with non-speciﬁc upper GI symptoms
(NS) and patients with a recent diagnosis of cancer of the
upper GI tract (CA).
Methods
Ethics approval
The Medical Ethical Review Board of Erasmus
MC—University Medical Center Rotterdam, The Nether-
lands, approved of the study (MEC 03.1064; October 9,
2003).
Patients
– Patients undergoing upper GI endoscopy for surveillance
of BE were participants of an ongoing trial (CYBAR),
whose endoscopic burden was previously reported [16].
Inclusion criteria were: BE segment of 2 cm or more
conﬁrmed by a histological diagnosis of intestinal
metaplasia, absence of high-grade dysplasia and carci-
noma, willingness to adhere to endoscopic surveillance,
ability to read the Dutch language and informed consent.
– Patients with non-speciﬁc upper GI symptoms (NS) were
referred for endoscopy by their respective GPs because
of non-speciﬁc upper GI symptoms. They needed to be
able to read the Dutch language, provide informed
consent, not to have ‘‘alarm symptoms’’ such as
hematemesis, melena, or dysphagia, and not be diag-
nosed with BE previously.
– Patients with a recent diagnosis of upper GI cancer (CA)
were referred for upper GI endoscopy plus ultrasonog-
raphy (EUS) to determine therapeutic options. Ability to
read the Dutch language and to give informed consent
was also required in these patients. Patients were
recruited from one academic and two regional hospitals
for BE, two regional hospitals for NS and in one
academic hospital for CA.
Endoscopic procedure
BE and NS patients underwent endoscopy with adult en-
doscopes (Olympus GIF-Q160, Zoeterwoude, The Neth-
erlands). In the group of cancer patients, a combined
endoscopy and EUS was performed with a Olympus GF-
UM160. More than 95% of patients received oral anaes-
thetics (Xylocain 10% spray, Astra Zeneca, Zoetermeer,
1310 Qual Life Res (2007) 16:1309–1318
123The Netherlands) preceding the introduction of the endo-
scope. Additional sedation with 2,5-5 mg midazolam
(Roche, Woerden, The Netherlands) intravenously was
offered as a standard procedure to all cancer patients, but
was only administered with explicit patient consent. In BE
and NS patients this was not standard, but it was admin-
istered on a patient’s request. Practice variations between
and within countries in the use of sedation for upper GI
endoscopy are common [17].
Hypotheses
Perceived burden of endoscopy was operationalised as pain
and discomfort during the procedure, symptoms afterwards
and psychological distress over time. We hypothesized that
subjects who had previous endoscopies may get used to it
to some extent and hence report less burden. Demographic
characteristics (age, sex, educational level, employment
status, etc) were considered as potential confounders. We
expected that BE patients may get used to regular endos-
copy to some extent, and that they adhere to surveillance
expecting that the test result will be reassuring. Therefore,
we expected BE patients to report less discomfort and
burden than the patients with non-speciﬁc GI symptoms,
who had less endoscopy experience. We also expected the
BE group to report less burden from the endoscopy than the
cancer patients, due to the endoscopy itself (combined with
EUS in the cancer patients) and the fact that cancer patients
were aware of their generally bad prognosis. Table 1 shows
the potential determinants of perceived burden of endos-
copy between patient groups.
Questionnaires and measurements
Patients were asked to complete questionnaires at different
time points, i.e., one week before the endoscopy (baseline),
at the day of endoscopy (just before undergoing it), one
week and one month after endoscopy [16]. In order to
minimize the questionnaire load for CA patients they re-
ceived only two questionnaires: the ﬁrst on the day of
endoscopy and the other one week afterwards. Some
baseline items had to be included in the ‘endoscopy day’
questionnaire in the CA group. The content of the ques-
tionnaires is described below.
Pain and discomfort
Separate items in the questionnaire one week after endos-
copy were used to assess pain and discomfort, respectively,
as experienced during the procedure, for four steps of the
procedure: the introduction of the endoscope, the endos-
copy itself, the removal of the endoscope, and the period
directly after endoscopy. Subjects were offered three
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123response options (‘no’, ‘quite’ and ‘very’ painful or dis-
comforting, respectively). Additionally, patients rated the
overall burden of undergoing the endoscopy (very, some-
what, not burdensome) [16].
Symptoms
We compared the prevalence of 10 symptoms experienced
in the week after endoscopy with the prevalence at baseline.
For CA patients, the baseline questions were asked at the
day of endoscopy. Presence of throat ache, heartburn,
regurgitation, ﬂatulence or feeling bloated, vomiting, he-
matemesis, dysphagia for solid foods or for of liquids,
diarrhea, and constipation, was assessed using four response
options (not at all, one day, 2–3 days, 4 or more days) [16].
Psychological distress (BE and NS patients)
We assessed general distress using the Hospital Anxiety
and Depression scale (HAD) at all time points [18, 19].
Anxiety and depression scores of this scale range from 0–
21, with scores of 11 or over indicating clinical, and scores
between 8 and 10 indicating borderline anxiety or depres-
sion [18, 19]. We analysed the pattern of scores across
measurements, assuming scores to return to normal after
endoscopy. Scores from a Dutch general population sample
(n = 1901; mean age = 61 year; 51% female) were avail-
able for comparison [19].
At baseline and at one week we also measured speciﬁc
distress with the Impact of Event Scale (IES) [20, 21]. At
baseline we assessed intrusive and avoiding thoughts
regarding the endoscopy itself, and at one week regarding
the communication of the ﬁnal test result. The total scale
ranges between 0 and 75, with scores of 26 or over indi-
cating a high risk of developing a stress disorder [22].
Psychological distress (CA patients)
For CA patients we omitted the HAD and the IES measures
regarding the endoscopy itself, because we expected that
distress in these patients was already at the top of the scale,
making any additional distress caused by the procedure itself
indiscernible. The IES to assess speciﬁc distress regarding
the endoscopy result was included in the questionnaire at the
day of endoscopy, because these patients received the
endoscopy results earlier than the next questionnaire.
Demographics and other data
Demographic data were collected at baseline (at the
endoscopy day for CA patients). The EQ–5D self-classiﬁer
results in a patient’s classiﬁcation of own health on ﬁve
domains: mobility, self-care, usual activities, pain, and
anxiety and depression (3 response options: no, some, se-
vere/ complete limitations) and a summary score [23–25].
We asked BE and NS patients whether this was their ﬁrst,
second or a later endoscopy. Whether sedation was used
during endoscopy was recorded separately.
Analyses
Differences in demographic and treatment characteristics
between patient groups were analysed by Chi-square tests
for categorical variables or one-way analysis of variance
(ANOVA) for continuous variables.
The items for pain and discomfort were combined into
summary scores to enable adjustment for confounders and
analysis of determinants, by adding up the item responses
(0, 1, 2, respectively) of the 4 items (range of pain and
discomfort summary scores: 0 (no pain or discomfort) to 8)
[16]. The response to the single item rating of overall
burden was also treated as a summary score, with a range
from 0 (no burden) to two [16]. Because these summary
scores had a limited number of possible values and because
the data were not distributed normally, we chose to analyse
them with proportional odds models [26]. These models
produce odds-ratios (ORs) for cumulative probabilities of
the outcome variables. Proportional odds models are a
variant of simple logistic regressions, but now ORs for
dichotomies at all possible cut-off levels are estimated.
E.g., for a variable with three possible outcomes 1, 2, and
3, ORs are estimated for (1 + 2) vs. 3 and for 1 vs. (2 + 3).
The OR presented represents an overall OR, that is as-
sumed to be similar across cut-off levels. Because some of
the outcome variables and determinants had 10–15%
missing data, and there were no reasons for selective
missing data, we used multiple imputation (function Are-
gImpute in Splus 6.0) [27] so that all available information
in our dataset was used. In multivariate analysis of the
determinants of patients’ perceived burden with the pro-
portional odds model, we ﬁrst adjusted for confounders
(age, sex and employment status). Subsequently we eval-
uated the potential effects of the following determinants on
discomfort, pain and overall burden, respectively:
– patient group (BE, NS or CA). This variable combines the
differences in the endoscopy procedure (with or without
EUS, sedation) and the indication to undergo the endos-
copy. For BE and NS patients, this analysis was reﬁned by
additional separate analysis of the effect of the number of
previous endoscopies (continuous, truncated at ‡20).
– baseline generic health status (EQ 5D summary score).
– whether sedation was administrated or not.
– baseline HAD anxiety score (not available for the CA
patients).
1312 Qual Life Res (2007) 16:1309–1318
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was compared using a method analogous to the Wilcoxon
test. Responses were ranked and ANOVA was applied to
the differences in these ranks [16].
The continuous HAD and IES scores were compared
over time in SAS version 8.2 with repeated-measures
ANOVA, using ‘Proc Mixed’ with REML and a compound
symmetry covariance structure. Models comprised main
effects of time (the measurements), confounders, determi-
nants and interactions between determinants and time.
Proportional odds models were estimated with Splus
6.0. All other analyses were conducted in SPSS version
11.0.1.
Results
Patients and response
In total, 684 patients were eligible for inclusion: 192 BE,
365 NS and 127 CA patients. The overall response rate was
70% with 476 patients completed at least one question-
naire. The response differed by patient group; it was 180/
192 (94%) in BE patients, 214/365 (59%) in NS patients
and 82/127 (65%) in CA patients. Most BE patient had no
dysplasia (78%), 22% had low-grade dysplasia [16]. NS
patients were diagnosed with hiatal hernia (45%), non-
speciﬁc gastritis (25%), reﬂux esophagitis (20%) and some
other diagnoses (e.g. ulcer, polyps; 10%). CA patients
underwent endoscopy and EUS for staging of esophageal
carcinoma (72%), gastric cancer (26%) or lymphoma (2%).
Differences between groups in mean age, sex and
employment status were statistically signiﬁcant (P < 0.001)
(Table 2). We therefore considered these variables as con-
founders and controlled for them in further analyses.
About 84% of the BE patients had had two or more
previous endoscopies [16], compared with 18% of the NS
patients (P < 0.001). Seventy-seven per cent of the CA
patients received sedation during endoscopy, compared
with 27% of the BE and 9% of the NS patients (P < 0.001).
The differences in the mean EQ–5D summary score were
in the expected direction (P < 0.001) (Table 2).
Pain and discomfort
Tables 3–5 show that the patient groups differed signiﬁ-
cantly in reported discomfort, pain and overall burden of
endoscopy. The p-values shown for the summary scores
relate to univariate analysis of differences between the
patient groups before adjustment for confounders.
Table 6 shows these adjusted differences in summary
scores for pair wise comparisons between the groups, and
how these are affected by the determinants. NS patients
reported signiﬁcantly more discomfort than BE patients, as
demonstrated by the signiﬁcant OR of 1.69. After adjusting
for differences in the number of previous endoscopies, the
difference in reported discomfort between NS and BE
patients was no longer signiﬁcant. Similarly, the difference
in reported discomfort between NS and BE patients could
also be explained by differences regarding the adminis-
tration of sedation. The differences between the NS and BE
groups in the baseline EQ–5D summary score and in
baseline anxiety scores did not explain the differences in
reported discomfort: the ORs remained signiﬁcant.
Reported pain during upper GI endoscopy did not differ
between NS and BE groups. The difference in reported
overall burden was signiﬁcant (OR = 1.64, P = 0.03). This
difference became also insigniﬁcant after adjustment for
the number of previous endoscopies and for sedation.
CA patients reported signiﬁcantly more pain
(OR = 2.69, P < 0.01) and overall burden than BE patients
(OR = 2.37, P < 0.01; Table 6). The differences in re-
ported pain could not be explained by differences in
baseline EQ–5D summary scores or whether sedation had
been administrated or not (all ORs remained signiﬁcant,
Table 6). CA and BE patients did not differ in reported
discomfort (OR = 1.22, P = 0.42), but after taking differ-
ences in the provision of sedation into account, the dif-
ference in reported discomfort became signiﬁcant
(OR = 2.06, P = 0.01).
Symptoms
After endoscopy, throat ache was the only symptom that
was reported more often than before the procedure (51 vs.
23%; P < 0.001). Other symptoms did not increase in
frequency. Compared to BE patients, the increase in throat
ache was smaller for NS patients and larger for CA patients
(P < 0.001); 31% of NS patients reported throat ache be-
fore and 46% afterwards, compared to12% and 47% of BE
patients, and 12% and 70% of CA patients, respectively.
Psychological distress
Figure 1 shows unadjusted mean anxiety and depression
scores (HAD—not available for CA patients) by patient
group over time.
After adjusting for confounders (repeated measures
ANOVA), anxiety levels were similar between the BE and
NS groups across measurements, but the pattern differed
signiﬁcantly between them (interaction effect of ‘group’
with ‘time’, P = 0.01): BE patients reported lower anxiety
levels at the start and slightly higher at the end. Determi-
nants (number of previous endoscopies, baseline EQ–5D
summary score, sedation) did not inﬂuence this pattern of
Qual Life Res (2007) 16:1309–1318 1313
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‘time’). Anxiety scores of both NS and BE patients were
signiﬁcantly higher at all time points than reported by a
general population sample (score = 3.9; P < 0.001 for each
group at each measurement) [19].
At all measurements, depression scores were lower in
BE than in NS patients (P < 0.001). This difference was
signiﬁcantly larger before than after endoscopy (interaction
effect of ‘group’ with ‘time’, P = 0.01). The number of
previous endoscopies affected the pattern of depression
over time (interaction effect of ‘number of previous en-
doscopies’ with ‘time’ P = 0.046) making the pattern of
the two groups more similar. Depression scores differed
from those reported by the general population sample: BE
patients reported signiﬁcantly lower levels at all measure-
ments, while baseline NS scores were signiﬁcantly higher
(norm score = 3.7, P < 0.001 for each comparison).
Speciﬁc distress (IES) scores regarding the endoscopy
itself and its outcome were lower in BE patients than in NS
patients (mean scores at baseline measurement and 1 week
measurements are BE 5.5 (sd 9.5), NS 12.9 (sd 14.7), and
BE 3.5 (sd 7.7), NS 9.4 (sd 14.3) respectively, P < 0.001).
The determinants did not affect this difference. In both BE
and NS patients, speciﬁc distress regarding the endoscopy
(IES, baseline measurement) was higher than regarding the
test result (IES, one week measurement) (P < 0.001). High
IES-distress scores regarding the endoscopy were seen in
51 patients (14%). CA patients (mean IES score 22.3 (sd
17.8)) had signiﬁcantly higher distress levels (IES)
regarding the test-result than the other patient groups
(P < 0.001).
Discussion
This study is the ﬁrst to investigate determinants of
patients’ perceived burden of upper GI endoscopy. Patients
undergoing endoscopy for different reasons reported a
different burden from the procedure. BE patients who
underwent endoscopy as part of regular surveillance,
reported the lowest discomfort, pain and overall burden,
conﬁrming our hypotheses in this respect. Patients with
non-speciﬁc GI complaints reported more discomfort from
the procedure, while those diagnosed with cancer experi-
enced more pain and both groups reported more overall
burden than patients under surveillance for BE. These
differences remained signiﬁcant after adjustment for con-
founders (age, sex, employment status). Differences in
Table 2 Patient characteristics
a
N.A., Not assessed
a Data for the BE group were
published previously [16]
b v- test (categorical variables)
or F-test (continuous) for
differences between patient-
groups
BE NS CA Differ
b N
Group 180 214 82 N.A. 476
Mean age (sd) 62 (12) 54 (16) 64 (10) <0.001 474
Sex: male 119 (66%) 101 (47%) 66 (80%) <0.001 476
Employment
Paid employment 59 (34%) 85 (44%) 25 (36%) <0.001 438
Retired 87 (50%) 65 (34%) 38 (54%)
Unpaid/unemployed 29 (17%) 43 (22%) 7 (10%)
Civil status
Married/ together 134 (77%) 137 (69%) 57 (80%) 0.034 444
Never married/ tog. 13 (7%) 26 (13%) 3 (4%)
Divorced 10 (6%) 23 (12%) 4 (6%)
Widowed 18 (10%) 12 (6%) 7 (10%)
Education
Primary 35 (20%) 37 (19%) 16 (23%) 0.498 435
Secondary 95 (56%) 122 (63%) 43 (61%)
Tertiary 40 (24%) 35 (18%) 12 (17%)
Hospital
Academic center (1) 37 (21%) 0 82 (100%) N.A. 476
Regional hospital (3) 143 (79%) 214 (100%) 0
Sedation: yes 43 (27%) 18 (9%) 56 (77%) <0.001 419
Endoscopy number
First 1 (1%) 99 (59%) Unknown <0.001 338
Second 26 (15%) 38 (23%)
Third or later 144 (84%) 30 (18%)
EQ–5D summary score 0.85 (0.18) 0.73 (0.22) 0.77 (0.21) <0.001 433
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123Table 3 Discomfort during
upper GI endoscopy as reported
by patients
a
a Data for the BE group were
published previously [16]
b Signiﬁcance of differences
between three groups as
determined by Chi-square test
(categorical variables) or
proportional odds models for
ordinal response data (summary
score). No correction for
confounders
Discomfort Not Quite Very n Differ
b
Introducing the endoscope 141 (34%) 177 (42%) 99 (24%) 417 P < 0.001
NS 42 (24%) 76 (43%) 58 (33%) 176
BE 64 (37%) 81 (47%) 27 (16%) 172
CA 35 (51%) 20 (29%) 14 (20%) 69
Undergoing endoscopy 166 (40%) 162 (39%) 89 (21%) 417 P=0.024
NS 62 (35%) 63 (36%) 51 (29%) 176
BE 75 (44%) 72 (42%) 25 (15%) 172
CA 29 (42%) 27 (39%) 13 (19%) 69
Removing the endoscope 290 (70%) 90 (22%) 35 ( 8%) 415 P < 0.001
NS 97 (55%) 52 (30%) 26 (15%) 175
BE 144 (84%) 24 (14%) 3 ( 2%) 171
CA 49 (71%) 14 (20%) 6 ( 9%) 69
Period immediately after 317 (78%) 71 (17%) 20 ( 5%) 408 P = 0.348
NS 132 (77%) 29 (17%) 11 ( 6%) 172
BE 136 (81%) 29 (17%) 4 ( 2%) 169
CA 49 (73%) 13 (19%) 5 ( 8%) 67
Discomfort summary score
(range: 0–8) Mean (sd)
All 2.35 (2.10) 406 P < 0.001
NS 2.92 (2.36) 171
BE 1.88 (1.69) 168
CA 2.07 (1.99) 67
Table 4 Pain during upper GI
endoscopy as reported by
patients
a
a Data for the BE group were
published previously [16]
b Signiﬁcance of differences
between three groups as
determined by Chi-square test
(categorical variables) or
proportional odds models for
ordinal response data (summary
score). No correction for
confounders
Pain Not Quite Very n Differ
b
Introducing the endoscope 332 (80%) 68 (16%) 17 (4%) 417 P = 0.050
NS 135 (77%) 29 (17%) 12 (7%) 176
BE 145 (85%) 24 (14%) 2 (1%) 171
CA 52 (74%) 15 (21%) 3 (4%) 70
Undergoing endoscopy 320 (77%) 77 (19%) 17 (4%) 414 P < 0.001
NS 141 (81%) 23 (13%) 10 (6%) 174
BE 137 (81%) 28 (17%) 5 (3%) 170
CA 42 (60%) 26 (37%) 2 (3%) 70
Removing the endoscope 365 (88%) 39 (9%) 11 (3%) 415 P = 0.098
NS 152 (87%) 16 (9%) 6 (3%) 174
BE 157 (92%) 11 (6%) 3 (2%) 171
CA 56 (80%) 12 (17%) 2 (3%) 70 P = 0.454
Period immediately after 350 (84%) 52 (13%) 15 (4%) 417
NS 147 (84%) 23 (13%) 6 (3%) 176
BE 145 (85%) 22 (13%) 4 (2%) 171
CA 58 (83%) 7 (10%) 5 (7%) 70
Pain summary score
(range: 0–8) Mean (sd)
All 0.86 (1.60) 413 P = 0.02
NS 0.91 (1.81) 173
BE 0.66 (1.35) 170
CA 1.20 (1.60) 70
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123baseline anxiety scores or in baseline general health (EQ–
5D) did not explain the differences in reported discomfort
or pain. Differences in the number of previous endoscopies,
and in whether sedation was provided during endoscopy or
not, explained part of the differences in reported discomfort
between NS and BE patients. Whether sedation was pro-
vided or not did not explain the differences in reported pain
and overall burden between BE and CA patients.
The study also conﬁrms that that upper GI endoscopy
is burdensome for all groups of patients: two-thirds of
the total group of patients reported discomfort and
overall burden from the procedure, and patients were
distressed beforehand. These results may however
underestimate the actual burden because this empirical
study was limited to patients who actually underwent
upper GI endoscopy, hence excluding patients who re-
frained from undergoing endoscopy because of past or
anticipated adverse experiences. Another potential limi-
tation of our study results from the differences in re-
sponse rates between the groups.
Differences between patient groups were also found for
symptoms resulting from the endoscopy. Of all symptoms
explored, only throat ache increased after upper GI
endoscopy. CA patients reported a higher increase in throat
ache than BE patients and NS patients. As upper GI
endoscopy hardly caused any symptoms, we considered an
investigation into determinants of these differences to be
less interesting and therefore omitted those analyses.
Furthermore, BE and NS patients differed in the levels
of generic (HAD) and speciﬁc (IES) distress they reported.
Speciﬁc distress (IES) was signiﬁcantly higher in NS
patients than in BE patients, both regarding the endoscopy
itself and its result. General distress (HAD) also differed
between groups: BE patients reported less depression
across all measurements and the pattern of anxiety and
depression across measurements was different. However,
Table 5 Overall burden of
upper GI endoscopy as reported
by patients
a
a Data for the BE group were
published previously [16]
b Signiﬁcance of differences
between three groups as
determined by Chi-square test
(categorical variable) or
proportional odds models for
ordinal response data (summary
score). No correction for
confounders
Overall burden Not Quite Very n Differ
b
Endoscopy in general 137 (34%) 204 (51%) 58 (15%) 399 P = 0.007
NS 48 (30%) 82 (50%) 32 (20%) 162
BE 68 (41%) 87 (52%) 12 ( 7%) 167
CA 21 (30%) 35 (50%) 14 (20%) 70
Overall burden summary
score (range: 0–2) Mean (sd)
All 0.80 (0.67) 399 P < 0.001
NS 0.90 (0.70) 162
BE 0.67 (0.61) 167
CA 0.90 (0.71) 70
Table 6 Differences in discomfort summary score, pain summary score and overall burden score, pair wise between patient groups (after
correction for age, sex and employment status as confounders); and effects of other determinants than patient group on these differences
Determinant Discomfort score Pain score Overall burden
OR
a 95% CI
b P-value OR
a 95% CI
b P-value OR
a 95% CI
b P-value
NS compared to BE (BE = reference group)
Patient group: NS versus BE 1.69 1.15–2.47 < 0.01 1.09 0.70–1.71 0.70 1.64 1.05–2.55 0.03
+ Number of previous endoscopies 1.49 0.98–2.27 0.06 1.19 0.73–1.94 0.50 1.56 0.96–2.53 0.07
+ Baseline EQ–5D 1.51 1.02–2.23 0.04 0.83 0.53–1.32 0.44 1.49 0.96–2.33 0.08
+ Baseline anxiety 1.63 1.12–2.39 0.01 1.04 0.66–1.64 0.86 1.59 1.02–2.49 0.04
+ Sedation 1.42 0.96–2.09 0.08 1.08 0.68–1.72 0.73 1.40 0.88–2.22 0.15
CA compared to BE (BE = reference group)
c
Patient group: CA versus BE 1.22 0.75–1.99 0.42 2.69 1.51–4.77 <0.01 2.37 1.38–4.07 <0.01
+ Baseline EQ–5D 1.07 0.66–1.74 0.79 2.32 1.29–4.18 <0.01 2.10 1.21–3.66 <0.01
+ Sedation 2.06 1.16–3.64 0.01 2.71 1.40–5.27 <0.01 3.10 1.68–5.74 <0.01
a Odds ratios were calculated by proportional odds models for ordinal response data. They show the differences between the patient groups,
corrected for confounders and the determinant mentioned
b 95% conﬁdence interval
c Numbers of previous endoscopies and baseline anxiety were not available for CA patients
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123general distress is not necessarily related to the endoscopy.
The persistent higher depression scores across different
time points suggest that NS patients have more depressive
symptoms in general but that this was not related to the
endoscopy. The different pattern of anxiety levels before
and after endoscopy, however, suggests that the patient
groups also differed in endoscopy-related distress. The
pattern corroborated the ﬁndings of the speciﬁc (IES) dis-
tress scores: NS patients were more distressed than BE
patients before the endoscopy. The investigated determi-
nants did not explain the differences between groups in
speciﬁc distress or general distress pattern, except for the
number of previous endoscopies explaining part of the
difference in the depression scores.
BE patients thus reported less distress and also less pain
or discomfort than other patient groups. This was not
caused by differences in patient characteristics (age, sex,
employment status, baseline anxiety, baseline general
health). There are several potential reasons why the
reported burden differs. Firstly, BE patients are under
regular surveillance and may get used to or adapt to the
procedure decreasing its burden. As the number of previous
endoscopies explained the lower distress, discomfort and
overall burden reported in the BE group, we conclude that
getting used, or adapting to endoscopy plays a role.
Secondly, patients who perceive a greater beneﬁt of the
test may weigh its burden differently and consequently
report less burden. BE patients potentially have more to
gain from early discovery of adenocarcinoma than NS
patients, who are usually referred for endoscopy to detect
potential explanations for their symptoms, and also more
than CA patients for whom endoscopy and ultrasonography
are only part of the procedure to determine their treatment
options and prognosis. As we did not measure perceived
expected beneﬁt of the endoscopy we are not able
to determine whether this mechanism is part of the
explanation.
Thirdly, the endoscopic procedure was slightly different
for the different patient groups. CA patients received
sedation more often. Adjusting for this difference into the
analysis did not explain the differences in pain and overall
burden, whereas the difference in reported discomfort be-
came signiﬁcant after adjustment for sedation. These re-
sults suggest that differences in the proportions of patients
receiving sedation during endoscopy did not explain the
differences between the groups, and that sedation was
provided to those patients who really needed it. The pro-
cedure for CA patients also differed; they underwent upper
GI endoscopy combined with ultrasonography, and for the
combined procedure an endoscope with a slightly larger
diameter is used. Our data did not allow us to test sepa-
rately whether this affected perceived pain and overall
burden. Finally, most CA patients had esophageal carci-
noma, and this disease may make passing the endoscope
through the esophagus more difﬁcult and therefore more
painful.
We measured general psychological distress (HAD) at
different time points; assuming that a pattern of higher
distress levels before compared to after endoscopy indi-
cates that the procedure causes distress. As discussed in a
previous paper [16], this may be debated for the reason
that lower distress levels afterwards may also result from
a reassurance effect of patients receiving a negative test
result (no serious disease present). Nevertheless, the fact
that the speciﬁc distress (IES) score relating to the
endoscopy was higher than the IES score relating to the
test outcome led us to conclude that the prospect of
undergoing upper GI endoscopy does indeed increase
distress levels.
Even if upper GI endoscopy causes HAD anxiety and
depression scores to be increased before the endoscopy, the
relevance of these increased distress levels can be ques-
tioned. Anxiety may be a relevant problem with 20% of
patients having scores indicating clinical anxiety levels at
baseline, while the depression scores are less worrisome
(6%). Endoscopy-speciﬁc distress (IES) was high in 14%
of patients and higher than the distress related to the out-
come. Anxiety scores in our study were increased com-
pared to general population scores at all time points.
Especially the fact that NS patients remained at increased
levels one month after endoscopy makes the comparability
of our scores with the population scores questionable [19].
General population scores are not available for procedure
speciﬁc-distress (IES), as this can only be measured in
patients. Considering the cut-off values for clinical scores,
the prospect of endoscopy causes moderate distress.
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Fig. 1 Differences between BE and NS groups in Hospital Anxiety
and Depression (HAD) scale scores for general distress before and
after upper GI endoscopy (mean scores, no adjustment for confound-
ers)
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123The observation that patients under regular endoscopic
surveillance may adapt to this invasive procedure should
not result in an underestimation of the burden of regular
endoscopic surveillance. The search for less invasive sur-
veillance tests should continue, and frequency of surveil-
lance should preferably be established by evidence-based
individualized estimates of risk of progression.
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